European Case Law Identifier: | ECLI:EP:BA:1988:T028186.19880127 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 27 January 1988 | ||||||||
Case number: | T 0281/86 | ||||||||
Application number: | 81201355.5 | ||||||||
IPC class: | C12N 15/29 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | A | ||||||||
Download and more information: |
|
||||||||
Title of application: | - | ||||||||
Applicant name: | Unilever | ||||||||
Opponent name: | - | ||||||||
Board: | 3.3.02 | ||||||||
Headnote: | There is no requirement under Article 83 EPC to the effect that a specifically described example of a process must be exactly repeatable. Variations in the constitution of an agent (here: genetic precursor) used in a process are immaterial to the sufficiency of the disclosure provided the claimed process reliably leads to the desired product (cf. point 6 of the Reasons). | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Sufficiency of disclosure Biological macromolecules Identical repeatability of examples |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t860281ex1.html
Date retrieved: 17 May 2021
13 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.EPO Guidelines - D Opposition and Limitation/Revocation Procedures
Offical Journal of the EPO
XOJ EPO SE 1/2021, p179 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2020)
XOJ EPO SE 1/2020, p174 - Annex 1 - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2019)
XOJ EPO SE 1/2019, p158 - XVI. - Index of published decisions of the boards of appeal and the Enlarged Board of Appeal - (as at 31 December 2018)